ANGUSTA
25MCG TBL NOB 8
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Cessation of marketing | 29.09.2021 |
0252447 |
Transfer of marketing authorisation | |
| Interruption of marketing | 21.09.2021 |
0002289 Lék obtížně nahraditelný (lék v jiné lékové formě, s jiným složením léčivých látek) |
Commercial/marketing reasons | 29.10.2021 |
| Resumption of marketing | 15.01.2021 | |||
| Interruption of marketing | 01.08.2020 | Lék není nahraditelný | Commercial/marketing reasons | 01.01.2021 |
| Placing on the market | 03.12.2019 | |||
| Placing on the market | 27.11.2019 |
All reports are available in the Overview.
cz